Head and Neck Tumors

  • Daniel T. T. Chua
  • Jonathan Sham
  • Kwan-Ngai Hung
  • Lucullus Leung


The technique of stereotactic radiosurgery has proved to be effective in the treatment of a variety of intracranial tumors, both benign and malignant, and abnormal conditions such as vascular malformations. Because of the proximity and the frequent involvement of the base of the skull, head and neck tumors as a group have also been explored as targets for extra-cranial radiosurgery. Because malignant head and neck tumors are usually highly aggressive and infiltrative, radiosurgery alone is seldom appropriate as the primary treatment modality for newly diagnosed disease. Radiosurgery, however, may offer significant benefits when used as a salvage treatment for recurrent disease or as a boost treatment after conventional radiotherapy. Among all the head and neck cancers, nasopharyngeal carcinoma (NPC) has attracted more attention with regard to the application of radiosurgery due to its unique location near the skull base, pattern of growth and invasion, relative radiosensitivity, and high incidence observed in some countries. In this chapter, the clinical results of using radiosurgery in the management of head and neck tumors are reviewed and discussed, with emphasis on the management of NPC.


Radiat Oncol Biol Phys Nasopharyngeal Carcinoma Local Failure Adenoid Cystic Carcinoma External Radiotherapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lee AW, Poon YF, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992; 23:261–270.PubMedGoogle Scholar
  2. 2.
    Lee AW, Sze WM, Au JS, et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 2005; 61:1107–1116.PubMedGoogle Scholar
  3. 3.
    Al-Sarraf M, LeBlanc M, Shanker Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol 1998; 16:1310–1317.PubMedGoogle Scholar
  4. 4.
    Chan AT, Teo PM, Ngan RK, et al. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in loco-regionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol 2002; 20:2038–2044.CrossRefPubMedGoogle Scholar
  5. 5.
    Lin JC, Jan JS, Hsu CY, et al. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progressionfree survival. J Clin Oncol 2003; 21:631–637.CrossRefPubMedGoogle Scholar
  6. 6.
    Chua DT, Ma J, Sham JST, et al. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials. J Clin Oncol 2005; 23:1118–1124.CrossRefPubMedGoogle Scholar
  7. 7.
    Chua DT, Sham JS, Kwong DL, et al. Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. Int J Radiat Oncol Biol Phys 1997; 39:711–719.PubMedGoogle Scholar
  8. 8.
    Wu PM, Chua DT, Sham JS, et al. Tumor control probability of nasopharyngeal carcinoma: a comparison of different mathematical models. Int J Radiat Oncol Biol Phys 1997; 37:913–920.PubMedGoogle Scholar
  9. 9.
    Kwong DL, Wei WI, Cheng AC, et al. Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma. Cancer 2001; 91:1105–1113CrossRefPubMedGoogle Scholar
  10. 10.
    Leung TW, Tung SY, Sze WK, et al. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2000; 47:405–412.CrossRefPubMedGoogle Scholar
  11. 11.
    Fee WE Jr, Roberson JB Jr, Goffinet DR. Long-term survival after surgical resection for recurrent nasopharyngeal cancer after radiotherapy failure. Arch Otolaryngol Head Neck Surg 1991; 117:1233–1236.PubMedGoogle Scholar
  12. 12.
    Morton RP, Liavaag PG, McLean M, et al. Transcervico-mandibulo-palatal approach for surgical salvage of recurrent nasopharyngeal cancer. Head Neck 1996; 18:352–358.CrossRefPubMedGoogle Scholar
  13. 13.
    King WW, Ku PK, Mok CO, et al. Nasopharyngectomy in the treatment of recurrent nasopharyngeal carcinoma: a twelve-year experience. Head Neck 2000; 22:215–222.CrossRefPubMedGoogle Scholar
  14. 14.
    Wei WI. Salvage surgery for recurrent primary nasopharyngeal carcinoma. Crit Rev Oncol Hemat 2000; 33:91–98.CrossRefGoogle Scholar
  15. 15.
    Teo PM, Kwan WH, Chan AT, et al. How successful is high dose (≥ 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys 1998; 40:897–913.CrossRefPubMedGoogle Scholar
  16. 16.
    Öksüz DÇ, Meral G, Uzel Ö, Çagatay P, Turkan S. Reirradiation for locally recurrent nasopharyngeal carcinoma: treatment results and prognostic factors. Int J Radiat Oncol Biol Phys 2004; 60:388–394PubMedGoogle Scholar
  17. 17.
    Chua DT, Sham JS, Kwong DL, et al. Locally recurrent nasopharyngeal carcinoma: treatment results for patients with computed tomography assessment. Int J Radiat Oncol Biol Phys 1998; 41:379–386.PubMedGoogle Scholar
  18. 18.
    Chang JT, See LC, Liao CT, et al. Locally recurrent nasopharyngeal carcinoma. Radiother Oncol 2000; 54:135–142.CrossRefPubMedGoogle Scholar
  19. 19.
    Lee AW, Foo W, Law SC, et al. Reirradiation for recurrent nasopharyngeal carcinoma: factors affecting the therapeutic ratio and ways for improvement. Int J Radiat Oncol Biol Phys 1997; 38:43–52.PubMedGoogle Scholar
  20. 20.
    Hsiung CY, Yorke ED, Chui CS, et al. Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2002; 53:638–647.PubMedGoogle Scholar
  21. 21.
    Lu TX, Mai WY, The BS, et al. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2004; 58:682–687.PubMedGoogle Scholar
  22. 22.
    Firlik KS, Kondziolka D, Lunsford LD, Janecka IP, Flickinger JC. Radiosurgery for recurrent cranial base cancer arising from the head and neck. Head Neck 1996; 18:160–166.CrossRefPubMedGoogle Scholar
  23. 23.
    Miller RC, Foote RL, Coffey RJ, et al. The role of stereotactic radiosurgery in the treatment of malignant skull base tumors. Int J Radiat Oncol Biol Phys 1997; 39:977–981.PubMedGoogle Scholar
  24. 24.
    Buatti JM, Friedman WA, Bova FJ, Mendenhall WM. Linac radiosurgery for locally recurrent nasopharyngeal carcinoma: rationale and technique. Head Neck 1995; 17:14–19.CrossRefPubMedGoogle Scholar
  25. 25.
    Kocher M, Juergen V, Susanne S, et al. Linear accelerator radiosurgery for recurrent malignant tumors of the skull base. Am J Clin Oncol 1998; 21:18–22.CrossRefPubMedGoogle Scholar
  26. 26.
    Cmelak AJ, Cox RS, Adler JR, Fee WE Jr, Goffinet DR. Radiosurgery for skull base malignancies and nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1997; 37:997–1003.PubMedGoogle Scholar
  27. 27.
    Chen HJ, Leung SW, Su CY. Linear accelerator based radiosurgery as a salvage treatment for skull base and intracranial invasion of recurrent nasopharyngeal carcinoma. Am J Clin Oncol (CCT) 2001; 24:255–258.CrossRefGoogle Scholar
  28. 28.
    Pai P, Chuang C, Wei K, et al. Stereotactic radiosurgery for locally recurrent nasopharyngeal carcinoma. Head Neck 2002; 24:748–753.CrossRefPubMedGoogle Scholar
  29. 29.
    Mitsuhashi N, Sakurai H, Katano S, et al. Stereotactic radiotherapy for locally recurrent nasopharyngeal carcinoma. Laryngoscope 1999; 109:805–809.CrossRefPubMedGoogle Scholar
  30. 30.
    Orecchia R, Redda MGR, Regona R, et al. Results of hypofractionated stereotactic re-irradiation on 13 locally recurrent nasopharyngeal carcinoma. Radiother Oncol 1999; 53:23–28.CrossRefPubMedGoogle Scholar
  31. 31.
    Ahn YC, Lee KC, Kim DY, et al. Fractionated stereotactic radiation therapy for extracranial head and neck tumors. Int J Radiat Oncol Biol Phys 2000; 48:501–505.PubMedGoogle Scholar
  32. 32.
    Xiao JP, Xu GZ, Miao YJ. Fractionated stereotactic radiosurgery for 50 patients with recurrent or residual nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2001; 51:164–170.PubMedGoogle Scholar
  33. 33.
    Tate DJ, Adler JR, Chang SD, et al. Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control. Int J Radiat Oncol Biol Phys 1999; 45:915–921.PubMedGoogle Scholar
  34. 34.
    Ryu S, Khan M, Yin F, et al. Image-guided radiosurgery of head and neck cancers. Otolaryngol Head Neck Surg 2004; 130:690–697.CrossRefPubMedGoogle Scholar
  35. 35.
    Elshaikh MA, Mahmoud-Ahmed AS, Kinney SE, et al. Recurrent head-and-neck chemodectomas: a comparison of surgical and radiotherapeutic results. Int J Radiat Oncol Biol Phys 2002; 52:953–956.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Daniel T. T. Chua
    • 1
  • Jonathan Sham
    • 1
  • Kwan-Ngai Hung
    • 2
  • Lucullus Leung
    • 3
  1. 1.Department of Clinical Oncology, Queen Mary HospitalThe University of Hong KongPokfulam, Hong Kong
  2. 2.Department of SurgeryThe University of Hong Kong, Queen Mary HospitalPokfulam, Hong Kong
  3. 3.Department of Clinical OncologyQueen Mary HospitalPokfulam, Hong Kong

Personalised recommendations